China's Shanghai Fosun wins race for India's Gland

China's Shanghai Fosun Pharmaceuticals has reportedly won a bidding war for India's privately held injectable maker Gland Pharma in a rare cross-…

South Africa's Aspen Pharmacare has set its sights on rapid expansion in China.

A dispute over the pricing of drugs in Pakistan that has led many of the pharmaceutical manufacturers in the country to stop making tuberculosis drugs is…

Zhejiang Hisun Pharmaceuticals has won China license rights to epithelial mAb oncology early-stage candidate pritumumab from Nascent Biotech.

India’s Sun Pharma Advanced Research Company has licensed its novel epilepsy drug Elepsia XR to its parent to speed up U.S. market entry following…

Changzhou Fangyuan Pharma is ready for clinical trials in China to test its nearly decade-long work on a tricky-to-make semisynthetic, methicillin-resistant…

Hanmi Pharmaceutical eyes branded drugs, fast-paced R&D and investment in China to get growth on track.